Dergiler / Turkish Journal of Biology / 2021 / Cilt: 45 - Sayı: 5

Investigation of the efficacy of paclitaxel on some miRNAs profiles in breast cancer stem cells

Sayfa
613–623
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Upregulation of miR-125b may be used as a biomarker for the prediction of response to paclitaxel treatment in breast cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Understanding of the functions of microRNAs in breast cancer and breast cancer stem cells have been a hope for the development of new molecular targeted therapies.
📊
Temel Bulgular & Veri:Here, it is aimed to investigate the differences in the expression levels of let-7a, miR10b, miR-21, miR-125b, miR-145, miR-155, miR-200c, miR-221, miR-222 and miR-335, which associated with gene and proteins in MCF-7 (parental) and MCF-7s (Mammosphere/stem cell-enriched population/CD44+/CD24-cells) cells treated with paclitaxel.
💡
Sonuç & Katkı:Upregulation of miR-125b may be used as a biomarker for the prediction of response to paclitaxel treatment in breast cancer.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Understanding of the functions of microRNAs in breast cancer and breast cancer stem cells have been a hope for the development of new molecular targeted therapies. Here, it is aimed to investigate the differences in the expression levels of let-7a, miR10b, miR-21, miR-125b, miR-145, miR-155, miR-200c, miR-221, miR-222 and miR-335, which associated with gene and proteins in MCF-7 (parental) and MCF-7s (Mammosphere/stem cell-enriched population/CD44+/CD24-cells) cells treated with paclitaxel. MCF7s were obtained from parental MCF-7 cells. Cytotoxic activity of paclitaxel was determined by ATP assay. Total RNA isolation and cDNA conversion were performed from the samples. Changes in expression levels of miRNAs were examined by RT-qPCR. Identified target genes and proteins of miRNAs were analyzed with RT-qPCR and western blot analysis, respectively. miR-125b was significantly expressed (2.0946-fold; p = 0.021) in MCF-7s cells compared to control after treatment with paclitaxel. Downregulation of SMO, STAT3, NANOG, OCT4, SOX2, ERBB2 and ERBB3 and upregulation of TP53 genes were significant after 48 h treatment in MCF-7s cells. Protein expressions of SOX2, OCT4, SMAD4, SOX2 and OCT4 also decreased. Paclitaxel induces miR-125b expression in MCF-7s cells. Upregulation of miR-125b may be used as a biomarker for the prediction of response to paclitaxel treatment in breast cancer.

🔖

Bu Makaleye Atıf Yap

ZEYBEK, Ü., KÜÇÜKALİ, C. İ., ERTÜRK, E., ARI, F., AKGÜN, O., ULUKAYA, E. (2022). Investigation of the efficacy of paclitaxel on some miRNAs profiles in breast cancer stem cells. Turkish Journal of Biology, Cilt: 45 - Sayı: 5, 613–623. https://ajindex.com/articles/600142

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Adhami M, Haghdoost AA, Sadeghi B, Malekpour Afshar R (2018). Candidate miRNAs in human breast cancer biomarkers: a systematic review. Breast Cancer 25 (2): 198–205. doi: 10.1007/ s12282-017-0814-8
  2. Akgun O, Erkisa M, Ari F (2019). Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin pathway inhibitors in lung carcinoma cells. Journal of Cellular Biochemistry 120 (9): 15467-15482. doi: 10.1002/jcb.28813 Andreotti PE, Cree IA, Kurbacher CM, Hartmann DM, Linder D et al. (1995). Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Research 55 (22): 5276–5282. Retrieved from http:// www.ncbi.nlm.nih.gov/pubmed/7585588 Ari F, Napieralski R, Ulukaya E (2013). Changes in gene methylation following chemotherapy in breast cancer cell lines. Turkish Journal of Biochemistry 38 (2): 34–42. doi: 10.5505/ tjb.2013.46320 Aztopal N, Erkisa M, Erturk E, Ulukaya E, Tokullugil AH et al. (2018). Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Chemico-Biological Interactions 280 51–58. doi: 10.1016/j.cbi.2017.12.003 Banzhaf-Strathmann J, Edbauer D (2014). Good guy or bad guy: The opposing roles of microRNA 125b in cancer. Cell Communication and Signaling 12 (1): 30. doi: 10.1186/1478- 811X-12-30
  3. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genetics 40 (5): 499–507. doi: 10.1038/ng.127 Bertoli G, Cava C, Castiglioni I (2015). Micrornas: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics, 5 (10): 1122–1143. doi: 10.7150/thno.11543 Bertoli G, Cava C, Castiglioni I (2016). The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer. Scandinavian Journal of Clinical and Laboratory Investigation 76: S34–S39. doi: 10.1080/00365513.2016.1208444 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68 (6): 394– 424. doi: 10.3322/caac.21492 Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer 6 (11): 857–866. doi: 10.1038/ nrc1997
  4. Chen J, Ren Q, Cai Y, Lin T, Zuo W et al. (2018)